In the state of insulin resistance, the insulin-stimulated NO pathway is selectively impaired and the compensatory hyperinsulinemia may activate the mitogen-activated protein kinase (MAPK) pathway, resulting in enhancement of vasoconstriction, pro-inflammation, endothelial dysfunction, increased sodium and water retention, and increases in blood pressure. The gene discussed is WNK2; the disease is Hyperinsulinemia.